These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24274870)

  • 1. The impact of obesity and metabolic syndrome on chronic hepatitis C.
    Goossens N; Negro F
    Clin Liver Dis; 2014 Feb; 18(1):147-56. PubMed ID: 24274870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of metabolic factors with HCV infection: does it matter?
    Bugianesi E; Salamone F; Negro F
    J Hepatol; 2012; 56 Suppl 1():S56-65. PubMed ID: 22300466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic syndrome and insulin resistance in patients with chronic hepatitis C].
    Baĭzhanova ZhZh; Ignatova TM; Nekrasova TP
    Ter Arkh; 2010; 82(10):51-6. PubMed ID: 21341465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    Negro F
    J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C infection and nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatty liver and hepatitis C virus infection].
    Lakatos M; Hagymási K; Lengyel G
    Orv Hetil; 2011 Sep; 152(38):1513-9. PubMed ID: 21896442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
    Hwang SJ; Lee SD
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical correlations of chronic hepatitis C, diabetes mellitus and steatohepatitis].
    Nemesánszky E
    Orv Hetil; 2011 May; 152(22):882-6. PubMed ID: 21565756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.
    Pais R; Rusu E; Ratziu V
    Clin Liver Dis; 2014 Feb; 18(1):165-78. PubMed ID: 24274872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis: co-factor in other liver diseases.
    Powell EE; Jonsson JR; Clouston AD
    Hepatology; 2005 Jul; 42(1):5-13. PubMed ID: 15962320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic hepatitis C, steatosis and insulin resistance--clinical implications].
    Lăcătuşu C; Mihai B; Graur M; Mihai C; Dranga M; Cijevschi-Prelipcean C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):306-15. PubMed ID: 21870716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and steatosis.
    Monto A
    Semin Gastrointest Dis; 2002 Jan; 13(1):40-6. PubMed ID: 11944633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM; McCullough AJ
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.
    Acalovschi M; Buzas C; Radu C; Grigorescu M
    J Viral Hepat; 2009 Dec; 16(12):860-6. PubMed ID: 19486279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.